rs864621986

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PS3PM2PP3_StrongPP5_Moderate

The NM_000528.4(MAN2B1):​c.1694T>C​(p.Leu565Pro) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). ClinVar reports functional evidence for this variant: "SCV006110274: The most pronounced variant effect results in <10% of normal activity when in trans with a pathogenic missense in patient leukocytes, with other in vitro studies in multiple cell lines corroborating a deleterious impact when p.Leu565Pro is expressed alone (example, Lipiski_2022, Riise_2012, Kuokkanen_2011).". Synonymous variant affecting the same amino acid position (i.e. L565L) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 31)

Consequence

MAN2B1
NM_000528.4 missense

Scores

11
7
1

Clinical Significance

Likely pathogenic criteria provided, single submitter P:1U:1

Conservation

PhyloP100: 7.18

Publications

3 publications found
Variant links:
Genes affected
MAN2B1 (HGNC:6826): (mannosidase alpha class 2B member 1) This gene encodes an enzyme that hydrolyzes terminal, non-reducing alpha-D-mannose residues in alpha-D-mannosides. Its activity is necessary for the catabolism of N-linked carbohydrates released during glycoprotein turnover and it is member of family 38 of glycosyl hydrolases. The full length protein is processed in two steps. First, a 49 aa leader sequence is cleaved off and the remainder of the protein is processed into 3 peptides of 70 kDa, 42 kDa (D) and 13/15 kDa (E). Next, the 70 kDa peptide is further processed into three peptides (A, B and C). The A, B and C peptides are disulfide-linked. Defects in this gene have been associated with lysosomal alpha-mannosidosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]
MAN2B1 Gene-Disease associations (from GenCC):
  • alpha-mannosidosis
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women's Health, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000528.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV006110274: The most pronounced variant effect results in <10% of normal activity when in trans with a pathogenic missense in patient leukocytes, with other in vitro studies in multiple cell lines corroborating a deleterious impact when p.Leu565Pro is expressed alone (example, Lipiski_2022, Riise_2012, Kuokkanen_2011).
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.963
PP5
Variant 19-12655830-A-G is Pathogenic according to our data. Variant chr19-12655830-A-G is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 208271.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000528.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAN2B1
NM_000528.4
MANE Select
c.1694T>Cp.Leu565Pro
missense
Exon 14 of 24NP_000519.2O00754-1
MAN2B1
NM_001440570.1
c.1697T>Cp.Leu566Pro
missense
Exon 14 of 24NP_001427499.1
MAN2B1
NM_001173498.2
c.1691T>Cp.Leu564Pro
missense
Exon 14 of 24NP_001166969.1O00754-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAN2B1
ENST00000456935.7
TSL:1 MANE Select
c.1694T>Cp.Leu565Pro
missense
Exon 14 of 24ENSP00000395473.2O00754-1
MAN2B1
ENST00000221363.9
TSL:1
c.1691T>Cp.Leu564Pro
missense
Exon 14 of 24ENSP00000221363.4O00754-2
MAN2B1
ENST00000964003.1
c.1742T>Cp.Leu581Pro
missense
Exon 14 of 24ENSP00000634062.1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
31

ClinVar

ClinVar submissions
Significance:Likely pathogenic
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
1
-
Deficiency of alpha-mannosidase (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.80
BayesDel_addAF
Pathogenic
0.42
D
BayesDel_noAF
Pathogenic
0.36
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.85
D
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.67
T
M_CAP
Uncertain
0.24
D
MetaRNN
Pathogenic
0.96
D
MetaSVM
Uncertain
0.26
D
MutationAssessor
Pathogenic
2.9
M
PhyloP100
7.2
PrimateAI
Uncertain
0.56
T
PROVEAN
Pathogenic
-4.7
D
REVEL
Pathogenic
0.86
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.0020
D
Varity_R
0.94
gMVP
0.91
Mutation Taster
=6/94
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs864621986;
hg19: chr19-12766644;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.